HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AndroGel safely and effe
![WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents](https://patentimages.storage.googleapis.com/ef/bb/1f/d41da8a542c4e1/imgf000014_0001.png)
WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents
![EP1317921A1 - Gel or solution containing dihydrotestosterone, its manufacture and use - Google Patents EP1317921A1 - Gel or solution containing dihydrotestosterone, its manufacture and use - Google Patents](https://patentimages.storage.googleapis.com/59/a7/12/59129bb50a88f7/00140001.png)
EP1317921A1 - Gel or solution containing dihydrotestosterone, its manufacture and use - Google Patents
Excel Male - DHT Gel Effectively Treats Gynecomastia in HIV + Men http://www.excelmale.com/showthread.php?6605-DHT-Gel-Effectively-Treats-Gynecomastia-in-HIV-Men | Facebook
![WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents](https://patentimages.storage.googleapis.com/b4/a8/ba/0344e6b669102d/imgf000019_0001.png)
WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents
![JPM | Free Full-Text | Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency JPM | Free Full-Text | Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency](https://www.mdpi.com/jpm/jpm-13-00992/article_deploy/html/images/jpm-13-00992-g004.png)